AUPH Earnings Aurinia Pharmaceuticals Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–27 of 27
| Q2 2026 | 2026-06-30 | 0.53 | 2026-08-06 | 10-Q |
| Q1 2026 | 2026-03-31 | 0.25 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | 2.07 | 2026-02-26 | 10-K |
| FY 2025 | 2025-09-30 | 0.23 | 2026-02-26 | 10-K |
| Q2 2026 | 2025-06-30 | 0.32 | 2026-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.16 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | 0.04 | 2026-02-26 | 10-K |
| FY 2025 | 2024-09-30 | 0.10 | 2026-02-26 | 10-K |
| FY 2025 | 2024-06-30 | 0.01 | 2026-02-26 | 10-K |
| FY 2025 | 2024-03-31 | -0.07 | 2026-02-26 | 10-K |
| FY 2025 | 2023-12-31 | -0.54 | 2026-02-26 | 10-K |
| FY 2024 | 2023-09-30 | -0.09 | 2025-02-27 | 10-K |
| FY 2024 | 2023-06-30 | -0.08 | 2025-02-27 | 10-K |
| FY 2024 | 2023-03-31 | -0.18 | 2025-02-27 | 10-K |
| FY 2024 | 2022-12-31 | -0.76 | 2025-02-27 | 10-K |
| FY 2023 | 2022-09-30 | -0.06 | 2024-02-15 | 10-K |
| FY 2023 | 2022-06-30 | -0.25 | 2024-02-15 | 10-K |
| FY 2023 | 2022-03-31 | -0.27 | 2024-02-15 | 10-K |
| FY 2023 | 2021-12-31 | -1.40 | 2024-02-15 | 10-K |
| FY 2022 | 2021-09-30 | -0.39 | 2023-02-28 | 10-K |
| FY 2022 | 2021-06-30 | -0.37 | 2023-02-28 | 10-K |
| FY 2022 | 2021-03-31 | -0.40 | 2023-02-28 | 10-K |
| FY 2022 | 2020-12-31 | -0.87 | 2023-02-28 | 10-K |
| FY 2021 | 2020-09-30 | -0.34 | 2022-02-28 | 10-K |
| FY 2021 | 2020-06-30 | -0.24 | 2022-02-28 | 10-K |
| FY 2021 | 2020-03-31 | -0.23 | 2022-02-28 | 10-K |
| FY 2021 | 2019-12-31 | -0.95 | 2022-02-28 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.